Fulgent Genetics, Inc.

FLGT · Nasdaq · SIC 8071: Services-Medical Laboratories
135
SEC Filings

Business Summary

PART I . Overview We are a technology-based company with a well-established laboratory services business and a therapeutic development business. Our laboratory services business includes technical laboratory and testing services and professional interpretation of laboratory results by licensed physicians. Our therapeutic development business is focused on developing product candidates for treating a broad range of cancers using a novel nanoencapsulation and targeted therapy platform designed to ...

Next Earnings

Q2 FY2026 — expected 2026-07-12

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionFLGTdiscussed_in_filing Cybersecurity
topic_mentionFLGTdiscussed_in_filing Cybersecurity
topic_mentionFLGTdiscussed_in_filing Healthcare & Bio
topic_mentionFLGTdiscussed_in_filing Platform & Ecosystem
topic_mentionFLGTdiscussed_in_filing Healthcare & Bio
topic_mentionFLGTdiscussed_in_filing Platform & Ecosystem

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-272025-12-310001193125-26-079169EDGAR109K words
2025-02-282024-12-310000950170-25-029512EDGAR—
2024-02-282023-12-310000950170-24-022233EDGAR—
2023-02-282022-12-310000950170-23-005178EDGAR—
2022-02-282021-12-310001564590-22-007366EDGAR—
2021-03-082020-12-310001564590-21-011526EDGAR—
2020-03-132019-12-310001564590-20-010617EDGAR—
2019-03-222018-12-310001564590-19-008991EDGAR—
2018-03-202017-12-310001564590-18-006239EDGAR—
2017-03-172016-12-310001564590-17-004681EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-072025-09-300001193125-25-271013EDGAR30K words
2025-08-012025-06-300000950170-25-101105EDGAR—
2025-05-022025-03-310000950170-25-062258EDGAR—
2024-11-082024-09-300000950170-24-123684EDGAR—
2024-08-022024-06-300000950170-24-089592EDGAR—
2024-05-032024-03-310000950170-24-052485EDGAR—
2023-11-032023-09-300000950170-23-058512EDGAR—
2023-08-042023-06-300000950170-23-038316EDGAR—
2023-05-052023-03-310000950170-23-018079EDGAR—
2022-11-072022-09-300000950170-22-022661EDGAR—
2022-08-042022-06-300000950170-22-014856EDGAR—
2022-05-052022-03-310000950170-22-007909EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-170001674930-26-000012EDGAR2K words
2026-02-270001193125-26-079152EDGAR—
2025-12-220001193125-25-328747EDGAR—
2025-11-070001193125-25-271006EDGAR—
2025-10-200001193125-25-242917EDGAR—
2025-08-010000950170-25-101103EDGAR—
2025-05-150000950170-25-072676EDGAR—
2025-05-020000950170-25-062257EDGAR—
2025-02-280000950170-25-029510EDGAR—
2024-11-080000950170-24-123681EDGAR—

135 total filings indexed. 103 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

AMS — AMERICAN SHARED HOSPITAL SERVICES ACON — Aclarion, Inc. ADVB — Advanced Biomed Inc. BDSX — BIODESIX INC BLLN — BillionToOne, Inc. BGLC — BioNexus Gene Lab Corp CSTL — CASTLE BIOSCIENCES INC CFOR — CapForce Inc.

Company Identity

CIK0001674930
TickerFLGT
ExchangeNasdaq
SIC8071: Services-Medical Laboratories
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 5f8093338f4ec7fa4e9df88046aa03133f8366cbb4f1b30d0ea743ce63fe9454
parent: 5c36f53a21dbb8a28ed1b99d411fc933500d048753580f6201c5513190ef197b
content hash: eb1425fb0dae7da2d120d0aefd970a90beb62445f6b4411758f2eb5939514f98
signed: 2026-04-13T04:45:04.416Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf